U.S. stock index futures rose on Wednesday as investors took heart from signs of progress in developing a COVID-19 vaccine, looking past record daily death rates in some states and brewing tensions between Washington and Beijing.

Gold rose to a one-week high on Wednesday, holding comfortably above the key $1,800 level, on safe-haven demand fuelled by concerns over brewing U.S.-China tensions and their impact on a global economy already reeling from the COVID-19 pandemic.

London-listed shares rose on Wednesday as signs of progress in developing a COVID-19 vaccine bolstered hopes of a swift post-pandemic economic rebound, while GlaxoSmithKline gained after a U.S. health panel voted in favour of its blood cancer drug.

London-listed shares rose on Wednesday as signs of progress in developing a COVID-19 vaccine bolstered hopes of a swift post-pandemic economic rebound, while GlaxoSmithKline gained after a U.S. health panel voted in favour of its blood cancer drug.

Japanese stocks rose on Wednesday to a five-week high as encouraging results from a coronavirus vaccine study and optimism about swift economic growth supported expectations that corporate earnings would pick up in the second half of the year.

Japanese stocks rose on Wednesday to a five-week peak as encouraging results from a coronavirus vaccine study and optimism about swift economic growth supported expectations that corporate earnings will pick up in the second half of the year.

Asian shares jumped on Wednesday as optimism about a coronavirus vaccine bolstered risk appetite while the euro rose to a four-month top on the prospect of stimulus ahead of a crucial EU summit.

Asian shares jumped on Wednesday as optimism about a coronavirus vaccine bolstered risk appetite while the euro rose to a four-month top on the prospect of stimulus ahead of a crucial EU summit.

Asian shares jumped on Wednesday as optimism about a coronavirus vaccine bolstered risk appetite while the euro rose to a four-month top on the prospect of stimulus ahead of a crucial EU summit.

Wall Street ended higher on Tuesday, led by a surge in the Dow Jones Industrial Average, as investors bought energy and materials stocks and looked beyond a recent surge in coronavirus cases.

Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash.

Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash.

Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash.

Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash.

Stock markets fell for the second day in a row on Tuesday, wiping out gains since the start of the year, as fear over the coronavirus is spreading even faster than the virus itself.

Stocks that moved heavily or traded substantially on Tuesday: Intuit, Moderna rise; Mastercard, Shake Shack fall

A clinical trial is expected to begin in April, with results expected as early as July, according to a report.

Stocks slumped on Wall Street and bond prices soared as fears spread that the widening virus outbreak will stunt the global economy as manufacturing and travel get choked off

Oxford Economics projects the coronavirus could wipe out $1.1 trillion from their baseline worldwide gross domestic product forecast if it morphs into a global pandemic. A more optimistic estimate from the firm anticipates the pandemic being contained within …

These are the stocks posting the largest moves in midday trading.

The drugmaker Moderna has shipped a potential coronavirus vaccine for humans to government researchers for testing

The Dow was set to open about 150 points higher this morning. But that's nowhere near the Dow's over-1,000 points, or 3.5% plunge, Monday.

The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

Global pharmaceutical companies may not see enough profitability from developing a Covid-19 vaccine.

Does Moderna's Cancer Breakthrough Make It a Good #Stock to Buy [ https://t.co/C0z04EBapV ] Moderna (MRNA-1.34) and its big pharma collaboration partner, Without any growth drivers to replace sagging #Covid19 vaccine #Sales, though,

Does Moderna's Cancer Breakthrough Make It a Good Stock to Buy Now? $MRNA https://t.co/rUztHkOo4w

3 Insiders at Moderna sold 96,181 shares last week for $12.3M $MRNA #Moderna #stockmarket #stock https://t.co/tjmxNTZfkA

RT @RipTorn18: @edumoment1 @RepMTG Wonder if she's sold her stock in Pfizer or Moderna yet!!

RT @erica4ou: We always talk about Pfizer, but how many got rich off MODERNA? Moderna stock went from: $19 in January 2020 to $449 in Se…

RT @IMPFneinPlural: Corporate science should never do mass experiments on animals, or economically disadvantaged peoples again, as long as…

RT @cynthiamckinney: UNBELIEVABLE: CDC INSTRUCTS US GOVERNMENT TO DESTROY ALL REMAINING STOCK OF JOHNSON & JOHNSON COVID-19 SHOTS (And what…

Let’s get ready and buy stock! @moderna_tx got their #birdflu #mRNAvaccines approved May 2023. Gearing of for another #pandemic. #DHHS says The spread of bird flu viruses from one infected person to a close contact is very rare. #insiders

RT @unhealthytruth: Breaking: Former Pussycat Dolls member Jessica Sutta discusses the adverse effects she experienced after receiving the…

RT @KanekoaTheGreat: Former Pussycat Dolls member Jessica Sutta discusses the adverse effects she experienced after receiving the Moderna m…

Moderna Stock: Everything You Need To Know | via @ashandpri https://t.co/TvrFzajRM0

RT @janeway888: What about the OTHER pHARM companies? 2-12-22 Moderna CEO [Bancel] deleted his Twitter account &sold $ 400 million worth…

Moderna stock looks like it’s about to come out w a cure for cancer

RT @erica4ou: Moderna stock went from: $19 in January 2020 to $449 in September 2021 We always talk about Pfizer, but how many got mega…

Check out this article: Stock Market Climbs As Services Sector Jumps; PayPal And Moderna Lead On Earnings https://t.co/4zIeHhHyqe #businessnews #finance #marketnews https://t.co/O5mHuvuXY6

RT @CRWestMI: @realstewpeters Trumps man Moncef Slaoui, whom T chose to head up Warp Speed to fast track the vax and chips was on the board…

RT @janeway888: What about the OTHER pHARM companies? 2-12-22 Moderna CEO [Bancel] deleted his Twitter account &sold $ 400 million worth…

Top 5 Trending Tickers in Fintwit now: (Pre-Market) 1. $SIDU Sidus +9.91% 2. $META Meta 0.0% 3. $TSLA Tesla +1.48% 4. $S SentinelOne -37.07% 5. $MRNA Moderna +0.84% #fintwit #stocks #StockMarket #Stock

$DOCS $MRNA - Better Healthcare AI Stock: Moderna vs. Doximity https://t.co/W83MWa3xwH

$DOCS $MRNA - Better Healthcare AI Stock: Moderna vs. Doximity https://t.co/BSHqAT8Des

$DOCS $MRNA - Better Healthcare AI Stock: Moderna vs. Doximity https://t.co/y4xu9JvKQR

$DOCS $MRNA - Better Healthcare AI Stock: Moderna vs. Doximity https://t.co/bM224Byf6n

$DOCS $MRNA - Better Healthcare AI Stock: Moderna vs. Doximity https://t.co/R3hPvfZFUC

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…

RT @janeway888: What about the OTHER pHARM companies? 2-12-22 Moderna CEO [Bancel] deleted his Twitter account &sold $ 400 million worth…

COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring? https://t.co/hkNYhTmM2c

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…

$MRNA Moderna to Present at Upcoming Conferences in June 2023 #trading https://t.co/1JSoOwnSZN

RT @CRWestMI: @realstewpeters Trumps man Moncef Slaoui, whom T chose to head up Warp Speed to fast track the vax and chips was on the board…

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…

RT @JamesMelville: Does Rishi Sunak still have any financial interest or stake in Theleme Partners, the hedge fund he co-founded, which own…